在以大于或等于250mg/m²的剂量给予紫杉醇3小时期间出现光幻视。 - Suppr

Suppr

超能文献

Photopsia during 3-hour paclitaxel administration at doses > or = 250 mg/m2.

作者信息

Seidman A D, Barrett S, Canezo S

出版信息

J Clin Oncol. 1994 Aug;12(8):1741-2. doi: 10.1200/JCO.1994.12.8.1741.

DOI:10.1200/JCO.1994.12.8.1741

PMID:7913722

Abstract

摘要

相似文献

Photopsia during 3-hour paclitaxel administration at doses > or = 250 mg/m2.在以大于或等于250mg/m²的剂量给予紫杉醇3小时期间出现光幻视。

J Clin Oncol. 1994 Aug;12(8):1741-2. doi: 10.1200/JCO.1994.12.8.1741.

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.以3小时输注紫杉醇作为转移性乳腺癌初始及挽救性化疗的II期试验。

J Clin Oncol. 1995 Oct;13(10):2575-81. doi: 10.1200/JCO.1995.13.10.2575.

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.多西他赛/紫杉醇每周给药用于经治转移性乳腺癌

Clin Breast Cancer. 2002 Dec;3(5):346-52. doi: 10.3816/CBC.2002.n.038.

One-hour paclitaxel infusion schedules: a phase I/II comparative trial.

Semin Oncol. 1995 Jun;22(3 Suppl 6):118-23.

A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.多柔比星与紫杉醇序贯治疗晚期乳腺癌的I/II期研究

Semin Oncol. 1996 Oct;23(5 Suppl 11):16-22.

Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.紫杉醇联合每周大剂量5-氟尿嘧啶/亚叶酸钙和顺铂治疗晚期乳腺癌。

Semin Oncol. 1996 Oct;23(5 Suppl 11):32-7.

Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancer.

Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-52-S17-57.

Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancer.

J Clin Oncol. 1996 Mar;14(3):783-91. doi: 10.1200/JCO.1996.14.3.783.

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

J Clin Oncol. 1994 Aug;12(8):1621-9. doi: 10.1200/JCO.1994.12.8.1621.

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.转移性乳腺癌患者中紫杉醇/表柔比星联合以及紫杉醇/表柔比星/环磷酰胺联合的Ⅰ期研究：法国的经验

Semin Oncol. 1997 Feb;24(1 Suppl 3):S8-12.

引用本文的文献

Carbonic anhydrase inhibitor alleviates retinal barrier toxicity in paclitaxel-induced retinopathy and macular edema by inhibiting CAXIV.碳酸酐酶抑制剂通过抑制 CAXIV 缓解紫杉醇诱导的视网膜病变和黄斑水肿的视网膜屏障毒性。

Int Ophthalmol. 2024 Nov 23;44(1):437. doi: 10.1007/s10792-024-03362-9.

Evaluation of Retinal Nerve Fiber Layer and Macular Thickness Pre- and Post-Chemotherapy With Carboplatin and Paclitaxel in Patients With Endometrial and Ovarian Cancer.子宫内膜癌和卵巢癌患者使用卡铂和紫杉醇化疗前后视网膜神经纤维层和黄斑厚度的评估

Cureus. 2023 Aug 22;15(8):e43943. doi: 10.7759/cureus.43943. eCollection 2023 Aug.

Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.用于治疗泌尿生殖系统癌症的抗肿瘤方案引起的潜在眼科副作用：综述

Cureus. 2022 Jul 26;14(7):e27266. doi: 10.7759/cureus.27266. eCollection 2022 Jul.

Tamoxifen retinopathy: a case report.他莫昔芬视网膜病变：一例报告。

Springerplus. 2015 Sep 17;4:501. doi: 10.1186/s40064-015-1258-2. eCollection 2015.

Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review.紫杉醇和/或顺铂诱导的眼神经毒性：病例报告及文献复习。

Onco Targets Ther. 2014 Jul 31;7:1361-6. doi: 10.2147/OTT.S65774. eCollection 2014.

Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report.多西他赛化疗致中毒性视神经病变 1 例报告

BMC Ophthalmol. 2014 Feb 24;14:18. doi: 10.1186/1471-2415-14-18.

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.癌症患者化疗的神经毒性并发症：临床体征与最佳管理

Drugs. 2003;63(15):1549-63. doi: 10.2165/00003495-200363150-00003.

Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case.

J Neurooncol. 1995;25(3):221-5. doi: 10.1007/BF01053155.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验